Aptevo Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 310 | 0.0193% |
Individual Insiders | 4,083 | 0.254% |
Institutions | 81,889 | 5.1% |
General Public | 1,520,553 | 94.6% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 876.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
39,342 | US$37.8k | 40.2% | no data | |||
11,745 | US$11.3k | 194% | no data | |||
7,942 | US$7.6k | -73.8% | 0.03% | |||
5,957 | US$5.7k | 0% | no data | |||
3,613 | US$3.5k | 11.3% | no data | |||
3,152 | US$3.0k | 0% | no data | |||
2,377 | US$2.3k | 0% | no data | |||
2,084 | US$2.0k | -58.5% | no data | |||
1,533 | US$1.5k | 68.1% | no data | |||
1,330 | US$1.3k | 3.91% | no data | |||
1,059 | US$1.0k | -2.22% | no data | |||
981 | US$941.7 | -42.7% | no data | |||
852 | US$817.9 | 41.5% | no data | |||
546 | US$524.2 | 43.7% | no data | |||
418 | US$401.2 | 48.8% | no data | |||
342 | US$328.3 | 0% | no data | |||
320 | US$307.1 | 0% | no data | |||
314 | US$301.4 | 0% | no data | |||
310 | US$297.6 | 1.31% | no data | |||
258 | US$247.7 | 3.2% | no data | |||
255 | US$244.8 | 0% | no data | |||
249 | US$239.1 | 0% | no data | |||
248 | US$238.0 | 0% | no data | |||
227 | US$218.0 | 0% | no data | |||
193 | US$185.3 | 0.52% | no data |